https://www.sciencedaily.com/news/health_medicine/lung_cancer/ Information about lung cancer symptoms and treatments. Explore the latest medical research on cancers including experimental treatments. en-us Wed, 15 Apr 2026 09:35:33 EDT Wed, 15 Apr 2026 09:35:33 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/lung_cancer/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/03/260326075550.htm Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can become trapped inside lysosomes within tumor cells, forming slow-release reservoirs that create uneven drug distribution. This means some cancer cells are heavily exposed while others are barely affected. Understanding this process could help doctors better tailor treatments and improve outcomes. Fri, 27 Mar 2026 08:31:17 EDT https://www.sciencedaily.com/releases/2026/03/260326075550.htm https://www.sciencedaily.com/releases/2026/03/260303201807.htm Researchers at Kobe University have developed an AI system that can detect acromegaly, a rare hormone disorder, by analyzing photos of the back of the hand and a clenched fist. The disease often develops slowly and can take years to diagnose, even though untreated cases may shorten life expectancy. Wed, 04 Mar 2026 11:59:51 EST https://www.sciencedaily.com/releases/2026/03/260303201807.htm https://www.sciencedaily.com/releases/2026/02/260206012229.htm Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are packed with immune-suppressing regulatory T cells. New research finally explains why. Scientists discovered that these T cells aren’t all the same: one subtype actually helps keep tumors in check, while another shields cancer from immune attack. The balance between these “good” and “bad” cells can determine whether a tumor grows or shrinks. Fri, 06 Feb 2026 11:03:34 EST https://www.sciencedaily.com/releases/2026/02/260206012229.htm https://www.sciencedaily.com/releases/2026/01/260120000323.htm Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have linked regular use to lower rates of endometrial and bowel cancer, likely because the drug dampens inflammation that fuels tumor growth. Researchers have even found it can interfere with genes cancer cells rely on to survive. Still, experts warn that long-term use carries risks and shouldn’t replace proven prevention strategies. Tue, 20 Jan 2026 03:47:11 EST https://www.sciencedaily.com/releases/2026/01/260120000323.htm https://www.sciencedaily.com/releases/2025/09/250918225016.htm Wildfires are no longer a seasonal nuisance but a deadly, nationwide health crisis. Fueled by climate change, smoke is spreading farther and lingering longer, with new research warning of tens of thousands of additional deaths annually by mid-century. The health costs alone could surpass all other climate damages combined, revealing wildfire smoke as one of the most underestimated threats of our warming world. Fri, 19 Sep 2025 07:53:58 EDT https://www.sciencedaily.com/releases/2025/09/250918225016.htm https://www.sciencedaily.com/releases/2025/09/250916221917.htm Rogue DNA rings known as ecDNA may hold the key to cracking glioblastoma’s deadly resilience. Emerging before tumors even form, they could offer scientists a crucial early-warning system and a chance to intervene before the disease becomes untreatable. Wed, 17 Sep 2025 21:33:46 EDT https://www.sciencedaily.com/releases/2025/09/250916221917.htm https://www.sciencedaily.com/releases/2025/06/250629033449.htm Smoke from wildfires and structural fires doesn t just irritate lungs it actually changes your immune system. Harvard scientists found that even healthy people exposed to smoke showed signs of immune system activation, genetic changes tied to allergies, and even toxic metals inside their immune cells. Mon, 30 Jun 2025 00:29:09 EDT https://www.sciencedaily.com/releases/2025/06/250629033449.htm https://www.sciencedaily.com/releases/2025/06/250610230533.htm Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as those of smokers without the disease. These overloaded cells are larger and trigger more inflammation, suggesting that pollution and carbon buildup not just smoking may drive the disease. Tue, 10 Jun 2025 23:05:33 EDT https://www.sciencedaily.com/releases/2025/06/250610230533.htm https://www.sciencedaily.com/releases/2025/06/250609060137.htm A breakthrough study from Keck Medicine of USC may have found a powerful new triple therapy for glioblastoma, one of the deadliest brain cancers. By combining Tumor Treating Fields (TTFields), which deliver electric waves into tumors, with immunotherapy and chemotherapy, researchers saw a major boost in survival. Mon, 09 Jun 2025 06:01:37 EDT https://www.sciencedaily.com/releases/2025/06/250609060137.htm https://www.sciencedaily.com/releases/2025/05/250520224245.htm Scientists and medics have developed an ultra-rapid method of genetically diagnosing brain tumors that will cut the time it takes to classify them from 6-8 weeks, to as little as two hours.The team utilized the new approach during 50 brain tumor surgeries to deliver rapid, intraoperative diagnoses. This approach has achieved a 100% success rate, providing diagnostic results in under two hours from surgery and detailed tumor classifications within minutes of sequencing. Tue, 20 May 2025 22:42:45 EDT https://www.sciencedaily.com/releases/2025/05/250520224245.htm https://www.sciencedaily.com/releases/2025/05/250515131836.htm A new, incision-free technique developed at UVA Health to treat debilitating brain lesions called cerebral cavernous malformations, or cavernomas, has shown great promise in early testing, halting the growth of the lesions almost entirely. Thu, 15 May 2025 13:18:36 EDT https://www.sciencedaily.com/releases/2025/05/250515131836.htm https://www.sciencedaily.com/releases/2025/04/250424165403.htm 'Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice. Thu, 24 Apr 2025 16:54:03 EDT https://www.sciencedaily.com/releases/2025/04/250424165403.htm https://www.sciencedaily.com/releases/2025/04/250423185925.htm Researchers have discovered that expansion of mutant blood cells, a phenomenon linked to aging, can be found in cancerous tumors, and this is associated with worse outcomes for patients. Wed, 23 Apr 2025 18:59:25 EDT https://www.sciencedaily.com/releases/2025/04/250423185925.htm https://www.sciencedaily.com/releases/2025/04/250410130742.htm Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer. Thu, 10 Apr 2025 13:07:42 EDT https://www.sciencedaily.com/releases/2025/04/250410130742.htm https://www.sciencedaily.com/releases/2025/04/250409115406.htm A new study by an international team of researchers revealed that a rare and large summertime phytoplankton bloom in the North Pacific Subtropical Gyre in the summer of 2018 was prompted by ash from Kilauea falling on the ocean surface approximately 1,200 miles west of the volcano. Wed, 09 Apr 2025 11:54:06 EDT https://www.sciencedaily.com/releases/2025/04/250409115406.htm https://www.sciencedaily.com/releases/2025/04/250401131309.htm A team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins. The team has combined these two techniques to identify and test a drug for a young patient's tumor in time to be used for their treatment. Their success in finding a new drug for the patient shows how the study of proteins, known as proteomics, can be a valuable complement to the established study of genes (genomics) in real-time cancer therapies. Tue, 01 Apr 2025 13:13:09 EDT https://www.sciencedaily.com/releases/2025/04/250401131309.htm https://www.sciencedaily.com/releases/2025/04/250401131014.htm Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts warn. Tue, 01 Apr 2025 13:10:14 EDT https://www.sciencedaily.com/releases/2025/04/250401131014.htm https://www.sciencedaily.com/releases/2025/03/250313130948.htm A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new research. Thu, 13 Mar 2025 13:09:48 EDT https://www.sciencedaily.com/releases/2025/03/250313130948.htm https://www.sciencedaily.com/releases/2025/02/250225122033.htm New findings question assumptions of cancer formation in individuals with the cancer-predisposition syndrome, neurofibromatosis type 1, and offer hope for a personalized approach to early cancer recognition including for those with similar conditions. Tue, 25 Feb 2025 12:20:33 EST https://www.sciencedaily.com/releases/2025/02/250225122033.htm https://www.sciencedaily.com/releases/2025/02/250218113823.htm The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering technique. Tue, 18 Feb 2025 11:38:23 EST https://www.sciencedaily.com/releases/2025/02/250218113823.htm https://www.sciencedaily.com/releases/2025/02/250213144435.htm When a tumour develops, it creates a structure around itself called the tumour stroma, within which blood and lymphatic vessels ensure nutritional and respiratory biological exchanges. Lymphangiogenesis, i.e. the development of lymphatic vessels, is generally associated with a poor prognosis, as it favours the spread of metastases to other organs. By studying the cells that make up the wall of lymphatic vessels, a team has made an unexpected discovery: an enzyme they express appears to play a key role in supporting immune cells, particularly when they are activated by anti-tumor treatments. These results could pave the way for improving the effectiveness of immunotherapies. Thu, 13 Feb 2025 14:44:35 EST https://www.sciencedaily.com/releases/2025/02/250213144435.htm https://www.sciencedaily.com/releases/2025/02/250212134500.htm Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system. Wed, 12 Feb 2025 13:45:00 EST https://www.sciencedaily.com/releases/2025/02/250212134500.htm https://www.sciencedaily.com/releases/2025/02/250211134626.htm Children exposed to second-hand smoke at home are more likely to show certain changes in the epigenome, which can alter the way genes are expressed. These epigenetic changes could influence the development of diseases in the future. Tue, 11 Feb 2025 13:46:26 EST https://www.sciencedaily.com/releases/2025/02/250211134626.htm https://www.sciencedaily.com/releases/2025/02/250210133016.htm Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues. Mon, 10 Feb 2025 13:30:16 EST https://www.sciencedaily.com/releases/2025/02/250210133016.htm https://www.sciencedaily.com/releases/2025/02/250207122748.htm Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies, and clues behind why these tumors don't respond to existing immunotherapies. Fri, 07 Feb 2025 12:27:48 EST https://www.sciencedaily.com/releases/2025/02/250207122748.htm https://www.sciencedaily.com/releases/2025/02/250204132410.htm A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block it. Tue, 04 Feb 2025 13:24:10 EST https://www.sciencedaily.com/releases/2025/02/250204132410.htm https://www.sciencedaily.com/releases/2025/01/250127123901.htm Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically. A research team has now investigated the effectiveness of a new type of therapy and achieved promising results: The active substance TVEC led to a reduction in the size of the basal cell carcinoma in all study participants, which not only improved surgical removal, but also led to a complete regression of the tumor in some of the patients. Mon, 27 Jan 2025 12:39:01 EST https://www.sciencedaily.com/releases/2025/01/250127123901.htm https://www.sciencedaily.com/releases/2025/01/250124151243.htm Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases formation. Fri, 24 Jan 2025 15:12:43 EST https://www.sciencedaily.com/releases/2025/01/250124151243.htm https://www.sciencedaily.com/releases/2025/01/250124151010.htm Researchers find blocking the KCNB2 gene can slow tumor growth, paving the way for next-gen treatments for childhood brain cancer. Fri, 24 Jan 2025 15:10:10 EST https://www.sciencedaily.com/releases/2025/01/250124151010.htm https://www.sciencedaily.com/releases/2025/01/250123110236.htm New research looked at how cancers arise in children who are predisposed to developing the childhood kidney cancer, Wilms tumor, which could help anticipate the development of tumors before they fully form. Thu, 23 Jan 2025 11:02:36 EST https://www.sciencedaily.com/releases/2025/01/250123110236.htm https://www.sciencedaily.com/releases/2025/01/250120113756.htm Researchers have determined how children's immune systems react to different kinds of cancer depending on their age. The study reveals significant differences between the immune response of children and adults, and has the potential to lead to new tailored treatments for children with cancer. Mon, 20 Jan 2025 11:37:56 EST https://www.sciencedaily.com/releases/2025/01/250120113756.htm https://www.sciencedaily.com/releases/2025/01/250116133431.htm Researchers have shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy. Thu, 16 Jan 2025 13:34:31 EST https://www.sciencedaily.com/releases/2025/01/250116133431.htm https://www.sciencedaily.com/releases/2025/01/250109125643.htm Researchers have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help doctors make more informed treatment decisions for people with stage 1 lung cancer, potentially reducing the risk of the cancer returning or spreading. Thu, 09 Jan 2025 12:56:43 EST https://www.sciencedaily.com/releases/2025/01/250109125643.htm https://www.sciencedaily.com/releases/2024/12/241220132857.htm Researchers have been able to identify at least three distinct subtypes of a rare type of bone cancer for the first time, which could transform clinical trials and patient care. Fri, 20 Dec 2024 13:28:57 EST https://www.sciencedaily.com/releases/2024/12/241220132857.htm https://www.sciencedaily.com/releases/2024/12/241217131240.htm Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer. Tue, 17 Dec 2024 13:12:40 EST https://www.sciencedaily.com/releases/2024/12/241217131240.htm https://www.sciencedaily.com/releases/2024/12/241211124517.htm The majority of children who started smoking tobacco at age 10 years or in their later teens continued to smoke until their mid-twenties. Continuous smoking from childhood significantly increased the risk of premature heart damage, a new study shows. Wed, 11 Dec 2024 12:45:17 EST https://www.sciencedaily.com/releases/2024/12/241211124517.htm https://www.sciencedaily.com/releases/2024/12/241210183516.htm The city of Berkeley's first-in-the-nation soda tax a decade ago, along with more recent Bay Area tax increases on sugar-sweetened drinks, have not only led to reduced sales. They are also associated with significant changes in social norms and attitudes about the healthfulness of sweet drinks. Tue, 10 Dec 2024 18:35:16 EST https://www.sciencedaily.com/releases/2024/12/241210183516.htm https://www.sciencedaily.com/releases/2024/12/241206002144.htm An MRI-based imaging technique predicts the response of ovarian cancer tumors to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models. Fri, 06 Dec 2024 00:21:44 EST https://www.sciencedaily.com/releases/2024/12/241206002144.htm https://www.sciencedaily.com/releases/2024/12/241203194354.htm Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumors have a long-term benefit for at least 20 years, while the benefit was more short-term for younger women with similar tumor characteristics who had not yet gone through the menopause. Tue, 03 Dec 2024 19:43:54 EST https://www.sciencedaily.com/releases/2024/12/241203194354.htm https://www.sciencedaily.com/releases/2024/11/241126135741.htm Cancer cells on the surface are thought to have natural advantages compared to cells deep within, which is why scientists have hypothesized tumors grow more in their periphery than in the core. A recent study found the opposite is true: tumors grow throughout their mass. The findings challenge the idea that a tumor is a 'two-speed' entity. Tue, 26 Nov 2024 13:57:41 EST https://www.sciencedaily.com/releases/2024/11/241126135741.htm https://www.sciencedaily.com/releases/2024/11/241120121936.htm A new study shows that cigarette-smoke induced changes to the microbiota resulted in increased severity of disease in mice infected with influenza A virus. Wed, 20 Nov 2024 12:19:36 EST https://www.sciencedaily.com/releases/2024/11/241120121936.htm https://www.sciencedaily.com/releases/2024/11/241114125646.htm Researchers have developed a three-dimensional mathematical model of prostate cancer. The model depicts various processes, including tumour growth, genetic evolution and tumour cell competition. Thu, 14 Nov 2024 12:56:46 EST https://www.sciencedaily.com/releases/2024/11/241114125646.htm https://www.sciencedaily.com/releases/2024/11/241112123020.htm Small cranial nerve tumors that can cause hearing loss, vertigo and ringing in the ears are often watched rather than treated, but a new study is set to change how the tumors, called vestibular schwannomas, are managed. Tue, 12 Nov 2024 12:30:20 EST https://www.sciencedaily.com/releases/2024/11/241112123020.htm https://www.sciencedaily.com/releases/2024/11/241111123400.htm Extracellular vesicles (EVs) loaded with customizable anti-cancer antisense oligonucleotides suppressed cancer growth. Mon, 11 Nov 2024 12:34:00 EST https://www.sciencedaily.com/releases/2024/11/241111123400.htm https://www.sciencedaily.com/releases/2024/11/241104142208.htm Researchers have uncovered new targets that could be the key to effectively treating glioblastoma, a lethal type of brain cancer. These targets were identified through a screen for genetic vulnerabilities in patient-derived cancer stem cells that represent the variability found in tumors. Mon, 04 Nov 2024 14:22:08 EST https://www.sciencedaily.com/releases/2024/11/241104142208.htm https://www.sciencedaily.com/releases/2024/10/241017132114.htm Research provides evidence that a drug used to slow the progression of the disease ALS shows promise in suppressing the self-renewing cancerous stem cells that challenge the present standards of care for these lethal grade 4 brain tumours. Thu, 17 Oct 2024 13:21:14 EDT https://www.sciencedaily.com/releases/2024/10/241017132114.htm https://www.sciencedaily.com/releases/2024/10/241009121238.htm Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor genes were more likely to benefit from adding the immunotherapy tremelimumab to a combination of durvalumab plus chemotherapy to overcome treatment resistance typically seen in this patient population. Wed, 09 Oct 2024 12:12:38 EDT https://www.sciencedaily.com/releases/2024/10/241009121238.htm https://www.sciencedaily.com/releases/2024/10/241008122345.htm A new tool detects the evolutionary advantages of multiple myeloma cells over the different treatments available. The information it provides can help prevent the tumor from becoming resistant to drugs. Tue, 08 Oct 2024 12:23:45 EDT https://www.sciencedaily.com/releases/2024/10/241008122345.htm https://www.sciencedaily.com/releases/2024/10/241002123143.htm Researchers discovered key factors that determine different disease progressions in rare lung tumors. Wed, 02 Oct 2024 12:31:43 EDT https://www.sciencedaily.com/releases/2024/10/241002123143.htm https://www.sciencedaily.com/releases/2024/09/240926132017.htm Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective. In recent years, immunotherapies have given patients renewed hope, albeit with relatively modest success. A team has succeeded in identifying a specific marker on the surface of tumour cells, and in generating immune cells carrying an antibody to destroy them. Furthermore, these cells, called CAR-T cells, appear to be capable of targeting diseased cells in the tumor that do not carry this antigen, while sparing healthy cells. Thu, 26 Sep 2024 13:20:17 EDT https://www.sciencedaily.com/releases/2024/09/240926132017.htm https://www.sciencedaily.com/releases/2024/09/240925123547.htm Researchers have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive tumors. Wed, 25 Sep 2024 12:35:47 EDT https://www.sciencedaily.com/releases/2024/09/240925123547.htm https://www.sciencedaily.com/releases/2024/09/240920112634.htm Researchers have used a drug screening platform they developed to show that an antidepressant, currently on the market, kills tumor cells in the dreaded glioblastoma -- at least in the cell-culture dish. Fri, 20 Sep 2024 11:26:34 EDT https://www.sciencedaily.com/releases/2024/09/240920112634.htm https://www.sciencedaily.com/releases/2024/09/240919115043.htm Researchers have found evidence that low oxygen levels in tumors could actually enhance some of the body's immune responses against cancer, in contrast with the general paradigm that hypoxia exclusively helps cancer progression. Their findings identified a macrophage subpopulation displaying more potent immune responses under low oxygen concentrations in tumors. Thu, 19 Sep 2024 11:50:43 EDT https://www.sciencedaily.com/releases/2024/09/240919115043.htm https://www.sciencedaily.com/releases/2024/09/240913145621.htm Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer immunotherapy is targeted for patients with lung cancer, melanoma and other solid tumours. Nineteen patients with advanced stage cancers received between one and nine doses of the immunotherapy treatment. Scientists have found the immunotherapy created an immune response against cancer and was well tolerated, with adverse events including fatigue, injection site pain and fever. Fri, 13 Sep 2024 14:56:21 EDT https://www.sciencedaily.com/releases/2024/09/240913145621.htm https://www.sciencedaily.com/releases/2024/09/240912135824.htm Researchers have identified five independent factors that predict cancer patients' response to checkpoint inhibitors (CPIs). The study validates these factors in more than 1,400 patients and diverse types of cancer. These findings provide a framework to interpret biomarkers of response to CPIs and suggest a future pathway to improve personalized cancer medicine. Thu, 12 Sep 2024 13:58:24 EDT https://www.sciencedaily.com/releases/2024/09/240912135824.htm https://www.sciencedaily.com/releases/2024/09/240912135720.htm New study and promising results from the first clinical trial in patients provide novel insights and new hope for one of the deadliest of cancers. Thu, 12 Sep 2024 13:57:20 EDT https://www.sciencedaily.com/releases/2024/09/240912135720.htm https://www.sciencedaily.com/releases/2024/08/240820124451.htm Men with metastatic castration-resistant prostate cancer should be treated primarily with second-generation hormone drugs, which offer better treatment response and longer life expectancy than chemotherapy. However, the effect depends on which mutations the patient's tumor carries, according to a new study. Tue, 20 Aug 2024 12:44:51 EDT https://www.sciencedaily.com/releases/2024/08/240820124451.htm https://www.sciencedaily.com/releases/2024/07/240724123019.htm New research has advanced our knowledge of multiple roles for PTPRK, a receptor tyrosine phosphatase linked to the regulation of cell-cell adhesion, growth factor signalling and tumor suppression. Through a characterization of the function of PTPRK in human cell lines and mice, the team distinguished catalytic and non-catalytic functions of PTPRK. The findings extend what is known about the signalling mechanisms involving PTPRK as a phosphatase and its role in colorectal health but also shed new light on the extent of its function via non-catalytic signalling mechanisms. Wed, 24 Jul 2024 12:30:19 EDT https://www.sciencedaily.com/releases/2024/07/240724123019.htm https://www.sciencedaily.com/releases/2024/07/240710130805.htm Researchers have built the first-ever molecular atlas of the human brain vasculature at single-cell resolution, spanning from early development to adulthood and through disease stages such as brain tumors and brain vascular malformations. Wed, 10 Jul 2024 13:08:05 EDT https://www.sciencedaily.com/releases/2024/07/240710130805.htm https://www.sciencedaily.com/releases/2024/07/240703131739.htm Bowel cancer cells have the ability to regulate their growth using a genetic on-off switch to maximise their chances of survival. Wed, 03 Jul 2024 13:17:39 EDT https://www.sciencedaily.com/releases/2024/07/240703131739.htm